Literature DB >> 7378987

Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.

D R Ambruso, T Hays, W J Zwartjes, D G Tubergen, B E Favara.   

Abstract

Lymphohistiocytic reticulosis with phagocytosis is a rare, familial disorder affecting infants and children. It is characterized by fever, pancytopenia, hepatosplenomegaly, and a rapidly fatal course. Prior attempts to treat this disease have been unsuccessful. We describe two patients with lymphohistiocytic reticulosis with phagocytosis and hyperlipidemia. A sibling of one patient had died of the same disease. One patient also had abnormal lymphocyte response to mitogens. Both patients who were treated with epipodophyllotoxin VP 16-213 (VP-16) had remission of their disease and resolution of hyperlipidemia. VP-16 appears to be an effective agent for treating lymphohistiocytic reticulosis with phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378987     DOI: 10.1002/1097-0142(19800515)45:10<2516::aid-cncr2820451008>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

Authors:  J D Lay; C J Tsao; J Y Chen; M E Kadin; I J Su
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Genetic analysis of familial erythrophagocytic lymphohistiocytosis.

Authors:  A Gencik; E Signer; H Müller
Journal:  Eur J Pediatr       Date:  1984-09       Impact factor: 3.183

3.  Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.

Authors:  M Aricò; L Nespoli; R Maccario; D Montagna; F Bonetti; D Caselli; G R Burgio
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

4.  Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.

Authors:  Theodore S Johnson; Catherine E Terrell; Scott H Millen; Jonathan D Katz; David A Hildeman; Michael B Jordan
Journal:  J Immunol       Date:  2013-11-20       Impact factor: 5.422

5.  Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.

Authors:  Helena Trottestam; Annacarin Horne; Maurizio Aricò; R Maarten Egeler; Alexandra H Filipovich; Helmut Gadner; Shinsaku Imashuku; Stephan Ladisch; David Webb; Gritta Janka; Jan-Inge Henter
Journal:  Blood       Date:  2011-09-06       Impact factor: 22.113

6.  Familial erythrophagocytic lymphohistiocytosis. A neuropathologic study.

Authors:  J J Martin; P Cras
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan.

Authors:  I J Su; R L Chen; D T Lin; K S Lin; C C Chen
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Familial erythrophagocytic reticulosis. Complete response to combination chemotherapy.

Authors:  M M Delaney; E A Shafford; A Al-Attar; J Pritchard
Journal:  Arch Dis Child       Date:  1984-02       Impact factor: 3.791

9.  Monoclonal proliferation of Epstein-Barr virus-infected T-cells in a patient with virus-associated haemophagocytic syndrome.

Authors:  T Noma; K Kou; I Yoshizawa; Y Kawano; T Miyashita; S Mizutani; J Yata
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

10.  Successful treatment of two cases of classical Hodgkin lymphoma-associated hemophagocytic lymphohistiocyosis with R-CEPP.

Authors:  Patrick J Boland; Livia T Hegerova; Sarah J Williams; Robert W McKenna; Veronika Bachanova; Craig E Eckfeldt
Journal:  Leuk Lymphoma       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.